About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: August 2008
Eye on FDA Opens Up YouTube Channel
It occurred to me that I can’t keep harping on pharmaceutical companies to delve into the YouTube world unless I also do it myself and so Eye on FDA has a new YouTube channel – check it out. And by … Continue reading
Posted in New and Social Media
2 Comments
GAO Issues Report on FDA Approval and Oversight of Mifeprex
From the GAO Report – In September 2000, the Food and Drug Administration (FDA), part of the Department of Health and Human Services (HHS), approved the drug Mifeprex for use in terminating early term pregnancy. FDA approved the drug under … Continue reading
Posted in Current Affairs
Comments Off on GAO Issues Report on FDA Approval and Oversight of Mifeprex
GSK Opens Up New YouTube Channel
GlaxoSmithKline opened a YouTube channel earlier this year that apparently was a beta for what they were eventually going to accomplish. GSKCIC opened up, had little added to it, and didn’t allow you to embed the vids, which was defeating … Continue reading
Posted in New and Social Media
Comments Off on GSK Opens Up New YouTube Channel
FDA Draft Report on BPA and FDA’s Credibility Gap
Earlier this year, the Canadian health authorities sounded an alarm about food and water containers that were made with bisphenol- A (BPA), prompting scrutiny in this country and action by state legislators in California (Carole Migden) and U.S. senators (Charles … Continue reading
Posted in Current Affairs, FDA Image
1 Comment
I Want to Hear From You
It is August – a surprisingly mild one so far in terms of humidity and temperature here inside the Beltway. Lots and lots of people are on vacation, sadly I am not one of them. I thought it a good … Continue reading
Posted in Miscellaney
Comments Off on I Want to Hear From You